Anchored in work undertaken by the firm's principals at Duke University Medical center, ZumaTek, Inc. is oranzied around development of leading-edge, dedicated whole-breast imaging technologies for enhanced 3D lesion detection. The ZumaTek x-ray CT scanner identifies small tumors in a patients uncompressed breast earlier than traditional screening mammograms. ZumaTeks imaging technology eliminates painful breast compression used in mammography and tomosynthesis while allowing for compressionless whole-breast and chest wall imaging, earlier and more accurate detection, significantly lower radiation dose, and lower patient anxiety. These factors will not only lead to an increase in participation rates, but also provide a large gain in market share for an imaging provider in a competitive space. The firm is also developing devices used to monitor the progress of radiation therapy or chemotherapy in breast cancer patients as it is able non-invasively to detect chemical changes in the cancer cells. The companys devices can also be combined with on-board biopsy or treatment devices.
